BlueCrest Capital Management’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

BlueCrest Capital Management’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-118,100	Closed	-$99K	–	1465
2018 Q4	$99K	Sell	118,100 -2,337	-2%	-$2.79K	0.01%	764
2018 Q3	$171K	Sell	120,437 -216,220	-64%	-$237K	﹤0.01%	1317
2018 Q2	$278K	Buy	+336,657	New	+$325K	0.01%	1152

Other funds holding CVRS

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlueCrest Capital Management's CVRS Position: Q1 2019 in Review

BlueCrest Capital Management sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q1 2019, closing a stake of 118,100 shares — an estimated $99K sold.

BlueCrest Capital Management first reported a position in CVRS in Q2 2018 and held it in 3 quarters. The position peaked at $278K in Q2 2018. 64 funds tracked by Wall St. Rank hold CVRS as of Q1 2019.

BlueCrest Capital Management reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q1 2019 after selling out during the quarter.
BlueCrest Capital Management sold 118,100 CORINDUS VASCULAR ROBOTICS, INC shares in Q1 2019, an estimated $99K.
BlueCrest Capital Management first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2018 and held it in 3 quarters.
BlueCrest Capital Management's CORINDUS VASCULAR ROBOTICS, INC position peaked at $278K in Q2 2018.
64 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q1 2019.

Based on BlueCrest Capital Management's 13F filing for Q1 2019, filed 15 May 2019.